Veralipride


Concise Prescribing Info
Indications/Uses
CV and psychological symptoms associated w/ menopause.
Dosage/Direction for Use
Adult : PO 100 mg/day for 20 days, repeat every 7-10 days.
Dosage Details
Oral
Cardiovascular and psychological symptoms associated with menopause
Adult: 100 mg daily for 20 days; repeated at intervals of 7-10 days.
Contraindications
Porphyria.
Special Precautions
Parkinson's disease.
Adverse Reactions
Depression, anxiety, sleep disorders, tremors, tardive dyskinesia. May worsen parkinsonism.
Action
Description: Veralipride is a substituted benzamide antipsychotic with antidopaminergic action. It was used to reduce frequency and severity of hot flushes associated with menopause, but was withdrawn in several European countries in 2007 as the risks of veralipride outweigh its benefits.
MIMS Class
Disclaimer: This information is independently developed by MIMS based on Veralipride from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in